Counter-Bioterrorism Reform Plan Looks Promising, Experts
Say
20 August 2010
By Matt Korade, CQ Staff
The Obama administration has struck out in a bold, new direction
by announcing an overhaul of the production of countermeasures to
bioterrorism and pandemic disease, observers say, adding that the
plan's more prosaic recommendations might be as important as its
eye-catching items.
The administration's planned new direction, released Thursday,
calls for reinvesting $1.9 billion in funding left over from last
year's response to the H1N1 "swine flu" pandemic. While some of
that money would go toward attention-getting proposals - such as
creating a new strategic investment agency to promote innovative
but struggling companies - experts also praised less catchy
recommendations, such as managerial changes to the countermeasure
development effort and a proposal to give the Food and Drug
Administration (FDA) $170 million to revamp the way it approves new
drugs and vaccines.
Full article
DISCLAIMER
The links and content above are provided for your convenience to provide further information and do not constitute an endorsement by Bavarian Nordic. We have no control over the nature, content and availability of the sites that are being linked to and thus we assume no responsibility for the privacy practices on such websites.
